Skip to main content
FSCDR's 17th Annual SCD Research and Educational Symposium & 46th Nat'l SCD Scientific Meeting Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Live Stream
Live Stream
Back
Live Stream

Investigational New Drug, Device and Therapeutics Symposium

CSL889 (Hemopexin) and Vamifeport as Potential Therapeutics in Sickle Cell Disease

Friday, June 16, 2023
5:05 PM – 5:15 PM East Coast USA Time
Location: Grand Salons A-E
Live Stream

    Speaker(s)

  • Paul Shore, MD, MS

    Clinical Program Director
    CSL Behring
    King of Prussia, Pennsylvania, United States

Disclosure(s):
Paul Shore, MD, MS: No relevant disclosure to display

Learning Objectives:

  • describe the mechanism of action of CSL889 (hemopexin) and its potential as a therapeutic for acute vaso-occlusive crisis in sickle cell disease
  • describe the mechanism of action of vamifeport and its potential as a therapeutic for sickle cell disease
  • list the clinical trials that are ongoing to evaluate CSL889 (hemopexin) and vamifeport in patients with sickle cell disease